Impact of new Rexod® injection form on blood microcirculation in rat skin

Background. Free radical oxidation underlies many morbid processes in various organs and tissues, including skin. A major antioxidant preventing the free radical impact is superoxide dismutase (SOD). A particularly valued SOD-containing agent is recombinant human SOD, Rexod, possessing a wide spectrum of medical applications in form of lyophilisate. Marketing of a new Rexod® injection preparation in form of solution requires research into its properties, including the impact on blood microcirculation in skin, especially with the lack of relevant clinical trials.

Objectives. Evaluation of anticipated positive effects of the new injection form of Rexod® on blood microcirculation in rat skin.

Мethods. The new Rexod® preparation impact on blood microcirculation in skin was studied with laser Doppler fl uometry by recording the following non-oscillatory parameters of the basal blood fl ow: microcirculation (MC), mean squared deviation (MSD) and coeffi cient of variation (CV). Blood fl ow fl uctuations were measured in a wavelet analysis at different frequency bands: 0.0095–0.02, 0.02–0.046, 0.07–0.15, 0.15–0.4 and 0.8–0.16 Hz corresponding to endothelial (Ae), neurogenic (An), myogenic (Am), respiratory (Ar) and pulse (Ap) rhythm amplitudes, respectively.

Results. The new Rexod® injection preparation at a dose of 8000 U/kg after 15 min of intraperitoneal administration in rats caused a statistically signifi cant (p < 0.05) increase in the blood fl ow fl uctuation amplitudes Ae (43.1%), An (43.4%), Am (60.8%), Ar (58.3%) and Ap (32.0%) compared to the control group. Because the Ae fl uctuations coincide with nitric oxide (NO) emission episodes, such a growth indicates an elevated NO excretion by endothelial cells leading to endothelium-dependent vasodilation. The observed changes in blood microcirculation in skin are also associated with higher integral values of the basal blood fl ow, MC (33.4% increase), MSD (14.0%) and CV (27.6%), although only MC and CV values were statistically signifi cant (p < 0.05). The results obtained suggest that the new injection form of Rexod® stimulates endothelial NO excretion, exerts adrenergic relaxation in smooth muscle cells of arteriolae and arteriovenular anastomoses, reduces precapillary sphincter and arteriolar contractility through Ca²⁺-dependent muscle relaxation, affects respiratory modulation of the venular blood microcirculatory compartment and vegetative cardiac support, intensifi es arterial blood fl ow by increasing the cardiac output.

Conclusion. Application of the new Rexod® injection form improves blood microdynamics in rat skin via stimulating endothelium-dependent and independent vasodilatation and endothelial metabolism, decelerating adrenergic vasomotor activity and peripheral microvascular resistance. These processes in coupling improve blood fl ow to nutritive microvascular bed and normalise venular outfl ow. Our results provide further insights into pharmacodynamics of recombinant human SOD (Rexod).

1. Shakhmardanova S.A., Gulevskya O.N., Seletskya V.V., Zelenskaya A.V., Khananashvili Ya.A., Nefedov D.A., Galenko-Yaroshevsky P.A. Antioxidants: classifi cation, pharmacological properties the use in the practice of medicine. Zhurnal Fundamental’noi Meditsiny i Biologii. 2016; 3: 4–15. (In Russ., English abstract).

2. Srivastava S., Singh D., Singh M.R. Folate-Conjugated Superoxide Dismutase Adsorbed Over Antioxidant Mimicking Nanomatrix Frameworks for Treatment of Rheumatoid Arthritis. J. Pharm. Sci. 2018; 107(6): 1530–1539. DOI: 10.1016/j.xphs.2018.01.026

3. Wang Y., Branicky R., Noë A., Hekimi S. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. J. Cell. Biol. 2018 Jun 4;217(6):1915–1928. doi: 10.1083/jcb.201708007

4. Ikelle L., Naash M.I., Al-Ubaidi M.R. Oxidative Stress, Diabetic Retinopathy, and Superoxide Dismutase 3. Adv. Exp. Med. Biol. 2019; 1185: 335–339. DOI: 10.1007/978-3-030-27378-1_55

5. Li J., Lei J., He L., Fan X., Yi F., Zhang W. Evaluation and Monitoring of Superoxide Dismutase (SOD) Activity and its Clinical Signifi cance in Gastric Cancer: A Systematic Review and Meta-Analysis. Med. Sci. Monit. 2019; 25: 2032–2042. DOI: 10.12659/MSM.913375

6. Zhao J.S., Jin H.X., Gao J.L., Pu C., Zhang P., Huang J.J., Cheng L., Feng G. Serum Extracellular Superoxide Dismutase Is Associated with Diabetic Retinopathy Stage in Chinese Patients with Type 2 Diabetes Mellitus. Dis. Markers. 2018; 2018: 8721379. DOI: 10.1155/2018/8721379

7. Romuk E., Jacheć W., Kozielska-Nowalany E., Birkner E., Zemła-Woszek A., Wojciechowska C. Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy. Cell Stress Chaperones. 2019; 24(3): 661– 673. DOI: 10.1007/s12192-019-00991-3

8. Saroyan K.V., Sytnik I.N., Soldatov V.O., Pershina M.A., Zhernakova N.I., Povetkin S.V., Sernov L.N. Endothelial dysfunction under infl uence of ionizing radiation: pathogenetic basis and opportunities of pharmacological correction. Kuban Scientifi c Medical Bulletin. 2018; 25(4): 124–131. (In Russ., English abstract). DOI: 10.25207/1608-6228-2018-25-4-124-131

9. Biosa A., Sanchez-Martinez A., Filograna R., Terriente-Felix A., Alam S.M., Beltramini M., Bubacco L., Bisaglia M., Whitworth A.J. Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss. Hum. Mol. Genet. 2018; 27(9): 1618–1629. DOI: 10.1093/hmg/ddy069

10. Jiang W., Bian Y., Wang Z., Chang T.M. Hepatoprotective effects of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] on alcohol-damaged primary rat hepatocyte culture in vitro. Artif. Cells. Nanomed. Biotechnol. 2017; 45(1): 46–50. DOI: 10.1080/21691401.2016.1191229

11. Nguyen C.T., Sah S.K., Zouboulis C.C., Kim T.Y. Author Correction: Inhibitory effects of superoxide dismutase 3 on Propionibacterium acnes-induced skin infl ammation. Sci. Rep. 2018; 8(1): 13150. DOI: 10.1038/s41598-018-31453-y

12. Shi Y., Hu X., Zhang X., Cheng J., Duan X., Fu X., Zhang J., Ao Y. Superoxide dismutase 3 facilitates the chondrogenesis of bone marrow-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 2019; 509(4): 983–987. DOI: 10.1016/j.bbrc.2019.01.042

13. Yoon Y., Kim T.J., Lee J.M., Kim D.Y. SOD2 is upregulated in periodontitis to reduce further infl ammation progression. Oral. Dis. 2018; 24(8): 1572–1580. DOI: 10.1111/odi.12933

14. Leontyev V.K., Tseluyko K.V., Zadorozhny A.V., Popkov V.L., Galenko-Yarochevsky P.A. The effect of combining nanosilver and new injection form of rexod on the periodontal tissues state on experimental periodontitis in rats. International Dental Review. 2020; 2(91): 12–16. (In Russ., English abstract). DOI: 10.35556/idr-2020-2(91):12–16

15. Shafranova S.K., Gaivoronskaya T.V., Kazaryan A.S., Paramonova O.A. Dynamics of morphological characteristics of the wound process in patients with odontogenic fl egmons in antioxidant therapy. Kuban Scientifi c Medical Bulletin. 2018; 25(5): 111–115. (In Russ., English abstract). DOI: 10.25207/1608-6228-2018-25-5-111-115

16. Seletskaya V.V., Galenko-Yaroshevsky P.A. Dermatoprotective activity of a combinaition of enoxifol with rexod in a reduced form the blood circulation in the skin in diabetes mellitus and hypercholinesterinemia. Research Results in Pharmacology. 2017; 3(1): 32– 48. DOI: 10.18413/2500-235X-2017-3-1-32-48

17. Shakhmardanova S.A., Gulevskya O.N., Seletskya V.V., Zelenskaya A.V., Khananashvili Ya.A., Nefedov D.A., Galenko-Yaroshevsky P.A. Antioxidants: classifi cation, pharmacological properties the use in the practice of medicine. Fundamental’noi Meditsiny i Biologii. 2016; 3: 16–30. (In Russ., English abstract).

18. Chuyan E.N., Ravayeva M.Y., Nefedov D.A., Zelenskaya A.V., Galenko-Yaroshevsky P.A. Dimephosphon effects on skin microhaemodynamics. Kuban Scientifi c Medical Bulletin. (In Russ., English abstract). 2017; (5): 90–95. DOI: 10.25207/1608-6228-2017-24-5-90-95

19. Galenko-Yaroshevsky P.A., Nefedov D.A., Zelenskaya A.V., Pavlyuchenko I.I., Chuyan E.N., Ravaeva M.Y., Tkharkakhova N.K. Effects of Dimephosphone on skin survival in conditions of reduced blood circulation. Research Results in Pharmacology. 2018; 4(4): 41–52. DOI: 10.3897/rrpharmacology.4.31880

20. Galenko-Yaroshevsky P.A., Popkov V.L., Bedrosova K.A., Faustov L.A., Sukoyan G.V., Zadorozhny A.V., Gulevskaya O.N., Uvarov A.V., Dobrodomova V.S. Benzofurocaine: effects on experimental periodontitis, anti-diabetic activity and molecular mechanisms of action. Research Results in Pharmacology. 2019; 5(1): 15–30. DOI: 10.3897/rrpharmacology.5.33100